| Literature DB >> 10099999 |
M L Swahn1, M Bygdeman, J K Chen, K Gemzell-Danielsson, S Song, Q Y Yang, P J Yang, M L Qian, W F Chang.
Abstract
In this two centre study, the efficacy of 200 mg mifepristone orally followed 48 h later by 0.4 mg misoprostol orally for menstrual regulation was investigated. The dose of mifepristone was taken the day before the expected day of menstruation. Each volunteer was planned to participate for up to 6 months. A plasma beta human chorionic gonadotrophin (HCG) was measured on the day of mifepristone intake. The study was disrupted prematurely due to low efficacy. In 125 treatment cycles the overall pregnancy rate was 17.6% (22 pregnancies) and the rate of continuing pregnancies (failure) was 4.0%. Eight women discontinued the study due to bleeding irregularities which were seen in 15 cycles (12%). These effects on bleeding pattern made the timing of treatment day difficult. Late luteal phase treatment with a combination of mifepristone and misoprostol is not adequately effective for menstrual regulation.Entities:
Keywords: Asia; Biology; China; Clinical Research; Developed Countries; Developing Countries; Eastern Asia; Endocrine System; Europe; Family Planning; Fertility Control, Postcoital; Gonadotropins; Gonadotropins, Chorionic; Gonadotropins, Pituitary; Hormone Antagonists; Hormones; Luteinizing Hormone; Menstrual Regulation; Misoprostol; Northern Europe; Physiology; Prostaglandins; Prostaglandins, Synthetic; Research Methodology; Research Report; Ru-486; Scandinavia; Sweden
Mesh：
Substances：
Year: 1999 PMID： 10099999 DOI： 10.1093/humrep/14.2.485
Source DB: PubMed Journal: Hum Reprod ISSN： 0268-1161 Impact factor: 6.918